Skip to the main content
Vetted Cases

Mass torts

What records matter after Depo-Provera use and a meningioma diagnosis?

Depo-Provera is a contraceptive injection. The drug in it is medroxyprogesterone acetate. A study published in the BMJ in March 2024 reported a higher rate of surgically treated intracranial meningioma among women who used the injection for a year or more. Cases against Pfizer are grouped in one federal court as MDL 3140. Whether any one diagnosis is connected to the drug is not settled.

Nothing on this page says the injection caused anyone's tumor, and nothing here says anyone has a claim. Starting a case check does not mean we represent you.

Written by the Vetted Cases team

Plain words. General information, not legal advice, and not medical advice.

Posted August 15, 2026Updated August 15, 2026

A kitchen table in daylight with a paper calendar, a pharmacy receipt, reading glasses and a notebook

Records, not recall

Injection dates may appear in the clinic file and, if a pharmacy dispensed the shot, its dispensing history. This page shows how to request both.

Where this comes from

You can open every source we used

We checked these original sources on August 15, 2026. Each link opens the source so you can read it for yourself.

Original links

Sources and what they explain

Judicial Panel on Multidistrict Litigation

JPML Transfer Order creating MDL No. 3140, February 7, 2025

Where it applies
Coverage stated by the source; location-specific rules vary
What it helps explain
The order that grouped the cases, with the list of cases it moved.
Date checked
Live public source; August 15, 2026
U.S. District Court, Northern District of Florida

In re: Depo-Provera Products Liability Litigation, MDL No. 3140

Where it applies
Coverage stated by the source; location-specific rules vary
What it helps explain
The court's own page for this litigation, with every order it has entered.
Date checked
Live public source; August 15, 2026
The BMJ

Roland N, et al. Use of progestogens and the risk of intracranial meningioma: national case-control study. BMJ 2024;384:e078078

Where it applies
Coverage stated by the source; location-specific rules vary
What it helps explain
The 2024 study, free to read, including the limits the authors set out themselves.
Date checked
Live public source; August 15, 2026
DailyMed, U.S. National Library of Medicine

DEPO-PROVERA (medroxyprogesterone acetate) injectable suspension, prescribing information

Where it applies
Coverage stated by the source; location-specific rules vary
What it helps explain
The current FDA-approved label. Meningioma is section 5.4, under Warnings and Precautions.
Date checked
Live public source; August 15, 2026

Where these cases stand

Litigation status

Court record read on August 15, 2026Updated when it changes.

Where the cases are
MDL No. 3140, In re: Depo-Provera (Depot Medroxyprogesterone Acetate) Products Liability LitigationAn MDL groups cases filed all over the country into one federal court for the early steps. It is not a class action. Each case stays its own case.Check it at the source (opens in a new tab)
The court and the judge
U.S. District Court for the Northern District of Florida, Pensacola Division. Judge M. Casey Rodgers, with Magistrate Judge Hope T. Cannon. Master docket 3:25-md-3140.The court posts its orders for this litigation publicly. Anyone can read them without an account.Check it at the source (opens in a new tab)
When the cases were grouped
February 7, 2025, by order of the Judicial Panel on Multidistrict Litigation.The panel groups cases when they raise the same questions of fact. Grouping says nothing about whether any of them will succeed.Check it at the source (opens in a new tab)
How many cases are in it
6,289 cases were pending in the MDL when the court wrote its case management order of August 10, 2026.The panel's own statistics report of August 3, 2026 counted 6,294. Two offices count on two different days, which is why a number like this only means something with a date attached.Check it at the source (opens in a new tab)Check it at the source (opens in a new tab)
Who the cases are against
Pfizer Inc., Pharmacia LLC, and Pharmacia & Upjohn Company LLC. The products named are Depo-Provera, Depo-SubQ Provera 104, and authorized generic versions.Naming a company in a complaint is an accusation. It is not a finding against that company.Check it at the source (opens in a new tab)
What the cases claim
The panel created MDL 3140 for plaintiffs who, in its words, allege they suffered intracranial meningiomas caused by use of Depo-Provera or a generic version of it.That sentence describes what the filings say. No court has decided whether the drug causes meningioma.Check it at the source (opens in a new tab)
Where it stands now
Lead counsel for the plaintiffs and the Pfizer defendants told the court they entered a settlement program, in an agreement the court's August 10, 2026 order dates July 22, 2026. On August 5, 2026 the court appointed a settlement administrator. The agreement is private and its terms are confidential, and the court's order records that the defendants admit no fault or liability.The court did not set the terms and does not decide who is covered. Eligibility is defined inside the agreement itself. Whether it reaches any one person is a question for a lawyer, not for this page.Check it at the source (opens in a new tab)Check it at the source (opens in a new tab)
The date the court wrote down
The court's order of August 10, 2026 states that the deadline for claimants to register for the settlement program is November 30, 2026.That is the settlement program's own registration date, copied from the order. It is not the legal deadline to bring a case, and this page does not tell anyone what their deadline is. Which time rules apply can depend on the claim and the places tied to it. Ask a lawyer who can assess those jurisdiction questions promptly.Check it at the source (opens in a new tab)
What the court has not decided
General causation and preemption were fully briefed by June 5, 2026. The court set the hearing on those motions for September 18, 2026. Its rulings apply to cases that are not eligible for the settlement program or that opt out of it.General causation is the question of whether the drug can cause this tumor at all. It is still open, and it is the question everything else rests on.Check it at the source (opens in a new tab)
Trials so far
The first trial in this MDL had been set for December 2026. After the settlement was announced the court canceled it, vacated the schedule for the pilot cases, and substituted three new pilot cases.A pilot case, sometimes called a bellwether, is tried early so both sides learn how juries respond. None has been tried here.Check it at the source (opens in a new tab)
Cases outside the federal group
Counsel reported to the court on July 27, 2026 that Depo-Provera cases were also pending in state courts: 410 in Delaware, 129 in New York, 118 in California, 72 in Minnesota, 13 in Connecticut, 12 in Illinois, and a handful in New Mexico, New Hampshire, Washington and Wisconsin.Where a case belongs depends on its own facts and on state law. The federal group is not the whole picture.Check it at the source (opens in a new tab)

Grouping cases together says nothing about whether any of them will succeed. When the legal facts change, this page changes with them.

The research

What the study found, in plain English

Sources read on August 15, 2026

People searching this subject are looking for the research as often as for the lawsuit. Here is what was published, what it reported, what its own authors say it cannot show, and what the approved label says.

The study people are reading about

Roland and colleagues, Use of progestogens and the risk of intracranial meningioma: national case-control study, published in the BMJ on March 27, 2024. It compared 18,061 women in France who had surgery for an intracranial meningioma with 90,305 matched women who did not.

It is a case-control study built on national health insurance records. It looks backward at what people were prescribed. Nobody was assigned a drug for the study.

What it reported for the injection

For injectable medroxyprogesterone acetate, the drug in Depo-Provera, the study reported 9 exposed women among the 18,061 surgery cases and 11 among the 90,305 controls. That is an odds ratio of 5.55, with a confidence interval running from 2.27 to 13.56. The authors reported the excess risk was driven by use of a year or more.

An odds ratio compares two groups of people. It is not a personal risk, and it does not say what caused any one tumor.

What the study does not establish

The injection finding rests on 9 exposed women, which is a small number and is why the confidence interval is so wide. The study counted only meningiomas treated with surgery, so tumors that were watched rather than operated on are not in it. It was done in France, where this injection is prescribed far less often than in the United States. And an association measured across a population does not establish what happened to any one person.

Researchers publish limits like these themselves. A page that leaves them out is selling something.

What the approved label says

The prescribing information for Depo-Provera CI, revised in December 2025, carries a Warnings and Precautions section on meningioma. It says cases of meningioma have been reported after repeated administration of medroxyprogesterone acetate, primarily with long term use, and it tells prescribers to monitor patients and to stop the drug if a meningioma is diagnosed.

A warning on a label is a safety instruction to doctors. It is not a finding that the drug caused any particular tumor.

What a higher rate means, and what it does not

  • A ratio compares two groups, not two people

    It describes how often something turned up in one group of people against another. It is not a forecast for any one woman, and it does not say what happened inside anybody's head.

  • A wide interval means the study could not pin it down

    A confidence interval is the range the researchers say the true figure probably sits in. When it is wide, that is the authors telling you the estimate is loose, usually because it rests on very few people.

  • An association is not a cause

    Two things showing up together in records is where research starts, not where it ends. Turning that into a finding about one person is the work of a court, and here that work is not finished.

This is why the page will not tell you what the injection did to you. Nobody reading a population study can answer that, and the question of whether the drug can cause this tumor at all is still in front of the court.

What a meningioma is

If you only recently heard the word meningioma, start with its plain meaning and the report that names what was found.

A meningioma grows from the layers of tissue that cover the brain and the spinal cord. The National Cancer Institute calls it the most common primary brain tumor. Grade 1 meningiomas are the most common kind and their cells grow slowly.

Many are found by accident, on a scan ordered for headaches or after a fall. Being handed the word once, in a hallway, is the usual experience of it.

It usually turns up on an MRI or a CT scan, and the report is the part with the words in it. The report names what was found and where it sits. If nobody has handed you that report, you can ask the hospital or the imaging center for it, and you do not have to say why.

Not every one of these is operated on. Watching it with repeat scans is common, and a woman who was never wheeled into surgery still has a diagnosis and still has a record of it. If there was surgery, the pathology report on the tissue is the document that names it most precisely.

Read the plain description at the source (opens in a new tab)

This is general information, not medical advice. Ask your doctor or another qualified clinician about symptoms, diagnosis, and treatment. Medical care may have a cost; using this case check does not.

What the filings have in common

Three things describe the cases that have been filed. They are a description of other people's paperwork, not a set of requirements, and none of them is a test anybody passes on a web page.

The injections went on for a while

The filings are about prolonged use rather than one or two shots, and the study reported that the excess it measured was driven by use of a year or more. The shot is usually given every three months, so a year is about four of them.

A tumor was found and named

The word in the court's own description of these cases is meningioma. It is written down in the radiology report, and in the pathology report if there was surgery. Being told something was found is not the same as having the report that names it.

The order of events matters

When the injections happened and when the diagnosis came are both part of the picture a lawyer reads. Approximate years are enough to start. The check ends with records that may confirm the dates.

Seeing your own history in that description settles nothing, and not seeing it settles nothing either. Whether a particular history and a particular diagnosis add up to a claim is what a lawyer decides after reading the records, and it is the one question this page refuses to answer.

Four questions, no form

Work out which records you need

Four questions. It organises what you already know, sets it beside what the filings have in common, and tells you which records to go and find.

This does not tell you whether you have a case, what a case is worth, or how long you have. Those answers come from a lawyer who has read your records.

Step 1 of 4. Did you receive Depo-Provera injections?

Your answers stay in this browser. Nothing is sent anywhere until you choose to start a case check, and you can close this page and take nothing with you but the list.

Did you receive Depo-Provera injections?

If you are not sure, say so. The next screen shows what it is called on a pharmacy or clinic record.

Did you receive the injections?

Call or text (435) 383-8833. Starting a case check does not mean we represent you.

The interactive version needs JavaScript. The same checklist is written out in full on the tool page, including who usually holds each record and how to ask for it.

Open the eligibility check

What happens when you contact us

Tell us what happened by phone, text or in writing. We keep the dates, records and questions together so a licensed attorney can read the full picture. The four-question check on this page is yours to use even if you never contact us.

Where you live is one factor in who can help. Depending on your state and what happened, another law firm may need to assist or handle the matter. We will name that firm and ask your permission before sharing anything.

See what to have ready

Questions people ask

Is there a Depo-Provera lawsuit?
There are thousands of separate cases, grouped in one federal court for the early steps as MDL 3140. An MDL is not a class action and there is nothing to join: each case stays its own case, brought by one person. The status band at the top of this page carries the court, the judge, the count the court itself published and the date somebody last read it, with a link to the order so you can check it yourself.
What is the connection between Depo-Provera and meningioma?
Research reported an association, and the approved label carries a warning about it. Neither of those is a finding that the injection caused any particular tumor. The cases in MDL 3140 allege that connection, and whether it holds up is the question the court has scheduled and has not answered. Anyone who tells you the connection is settled, in either direction, is ahead of the record.
What does the 2024 study actually say?
It compared women in France who had surgery for a meningioma against matched women who did not, using national health insurance records, and it reported a higher rate among women prescribed several progestogens, including the injection. For the injection specifically the finding rests on a very small number of women, which is why the range around it is so wide. The authors also note it counted only tumors treated with surgery. The research section on this page carries the numbers and the limits together, because either one alone is misleading.
How long did you have to use it?
There is no number on this page that determines an outcome, because that is not a question a web page can answer. The study reported that the excess it measured was driven by use of a year or more, and the filings concern prolonged use. An approximate count is enough for the check; clinic, pharmacy, and health-plan records may confirm the dates.
What if the diagnosis was years ago?
Say so and give the approximate date. Some older records may still be available. A health plan's claims history can show claims it processed by date of service, but it may omit self-paid, out-of-network or unsubmitted care. Time rules can depend on the claim and the places tied to it, which this page cannot determine. Ask a lawyer who can assess those jurisdiction questions promptly.
What does it cost to ask?
Nothing. The check on this page is free, needs no account, and gives its full answer without any contact information. Starting a case check is free and does not mean anyone represents you. You can also request your own medical and pharmacy records yourself, and you do not have to explain why you want them.

Exposed to something else at work? The firefighting foam page is written the same way

Sources

Every fact on this page comes from one of these, and each one is public. You do not need an account to read any of them.

  1. In re: Depo-Provera Products Liability Litigation, MDL No. 3140, U.S. District Court, N.D. Fla. (opens in a new tab)The court's own page for this litigation, with every order it has entered.
  2. Roland N, et al. Use of progestogens and the risk of intracranial meningioma: national case-control study. BMJ 2024;384:e078078 (opens in a new tab)The 2024 study itself, free to read, including the numbers behind the headline.
  3. MDL No. 3140 orders by date, U.S. District Court, N.D. Fla. (opens in a new tab)Every case management order and pretrial order, newest first.
  4. JPML Transfer Order and Schedule of Transferred Cases, February 7, 2025 (opens in a new tab)The order that created MDL 3140, with the list of cases it moved.
  5. Case Management Order No. 14, MDL No. 3140, entered August 10, 2026 (opens in a new tab)The court's order for the cases that keep litigating, with its own count of what is pending.
  6. Pending MDLs statistics reports, Judicial Panel on Multidistrict Litigation (opens in a new tab)The panel republishes these every few weeks. Find MDL 3140 in the list by district.
  7. Case Management Order No. 13, Appointment of Settlement Administrator, entered August 5, 2026 (opens in a new tab)The order naming who administers the settlement program.
  8. Case Management Order No. 12, MDL No. 3140, entered July 27, 2026 (opens in a new tab)The court's account of the July 2026 conference, including the motion schedule.
  9. DEPO-PROVERA (medroxyprogesterone acetate) injectable suspension, prescribing information, DailyMed (opens in a new tab)The current FDA-approved label. Meningioma is section 5.4, under Warnings and Precautions.
  10. Meningioma, National Cancer Institute (opens in a new tab)Plain description of the tumor, its grades and how it is diagnosed.

Attorney advertising. Past results do not guarantee future outcomes. The court details and dates on this page come from the public record for MDL 3140 and can change. Starting a case check does not mean we represent you.

A quick reality check

What this page can and cannot tell you

This page cannot decide whether Depo-Provera caused a diagnosis, whether anyone qualifies, case value or a legal deadline. A group-level study and a federal docket do not decide one person's medical or legal questions. Those require the full records and a licensed attorney's review.

When you are ready

You do not need every record to start

Tell us what happened and share what you already have. A licensed attorney can look at the full picture and ask about anything that is missing.

Start a case check

Last updated

August 15, 2026

We checked the answer and the links on this date.

You do not have to sort this out alone

Tell us roughly when you had the injections and what a doctor told you. That is enough to begin. A licensed attorney reads it and writes back with a plain next step, either way.

Open the four questions first
Start my case check

Call or text (435) 383-8833

Free to start. No obligation. Starting a case check does not mean we represent you.

Start my case check

Free to start. No obligation.

How would you like to start?

Pick whichever is easiest for you right now.

Free Go at your own pace No account needed

A licensed attorney reads every case check. Starting one does not mean we represent you. Representation begins only with a written agreement you choose to sign.